Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Fuji
Accenture
QuintilesIMS
Daiichi Sankyo
McKinsey
Express Scripts
Moodys

Generated: December 11, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,579,019

« Back to Dashboard

Summary for Patent: 7,579,019
Title:Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
Abstract:The present invention relates to a pharmaceutical delivery device for application of a pharmaceutical to mucosal surfaces. The device comprises an adhesive layer and a non-adhesive backing layer, and the pharmaceutical may be provided in either or both layers. Upon application, the device adheres to the mucosal surface, providing localized drug delivery and protection to the treatment site. The kinetics of erodability are easily adjusted by varying the number of layers and/or the components.
Inventor(s): Tapolsky; Gilles H. (The Woodlands, TX), Osborne; David W. (The Woodlands, TX)
Assignee: Arius Two, Inc. (Raleigh, NC)
Application Number:11/069,089
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,579,019
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device;

Drugs Protected by US Patent 7,579,019

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-001 Oct 23, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE ➤ Try a Free Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-002 Oct 23, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE ➤ Try a Free Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-003 Oct 23, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE ➤ Try a Free Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-004 Oct 23, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE ➤ Try a Free Trial
Bdsi BELBUCA buprenorphine hydrochloride FILM;BUCCAL 207932-005 Oct 23, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial TREATEMENT OF PAIN BY TRANSMUCOSAL DELIVERY OF BUPRENORPHINE ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,579,019

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 229322 ➤ Try a Free Trial
Austria 288743 ➤ Try a Free Trial
Australia 3892401 ➤ Try a Free Trial
Australia 3967899 ➤ Try a Free Trial
Australia 4757497 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Queensland Health
Baxter
Express Scripts
Cerilliant
Colorcon
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.